Mog (35-55)

Product Name: Mog (35-55)
CAS No.: 149635-73-4
Chemical Name: Mog (35-55)
Synonyms: MOG (35-55);MEVGWYRSPFSRVVHLYRNGK;MK21;MOG (35-55) TFA;MOG (35-55), RAT;MOG (MOUSE, RAT);MOG (35-55), MOUSE, RAT;MOG (RAT, MOUSE, 35-55);MOG (35-55) (rat, Mouse);H-MEVGWYRSPFSRVVHLYRNGK-OH
CBNumber: CB8355199
Molecular Formula: C118H177N35O29S
Formula Weight: 2581.95
MOL File: 149635-73-4.mol

More

Less

Mog (35-55) Property

Density: 1.48±0.1 g/cm3(Predicted)
storage temp.: -15°C
solubility: ≥32.25 mg/mL in H2O; insoluble in EtOH; ≥86 mg/mL in DMSO
form: solid
color: White to off-white
Water Solubility: Soluble to 0.50 mg/ml in water
Sequence: H-Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-VAL-His-Leu-Tyr-Arg-Asn-Gly-Lys-OH
InChI: InChI=1/C118H177N35O29S/c1-61(2)47-80(103(169)143-81(49-66-30-34-70(156)35-31-66)104(170)139-75(26-17-42-129-116(122)123)99(165)145-86(53-90(121)158)98(164)133-56-91(159)136-79(115(181)182)25-15-16-41-119)142-108(174)85(52-69-55-128-60-135-69)147-112(178)95(63(5)6)152-113(179)96(64(7)8)151-101(167)77(28-19-44-131-118(126)127)141-109(175)87(58-154)148-106(172)83(48-65-21-11-10-12-22-65)146-110(176)89-29-20-45-153(89)114(180)88(59-155)149-100(166)76(27-18-43-130-117(124)125)140-105(171)82(50-67-32-36-71(157)37-33-67)144-107(173)84(51-68-54-132-74-24-14-13-23-72(68)74)137-92(160)57-134-111(177)94(62(3)4)150-102(168)78(38-39-93(161)162)138-97(163)73(120)40-46-183-9/h10-14,21-24,30-37,54-55,60-64,73,75-89,94-96,132,154-157H,15-20,25-29,38-53,56-59,119-120H2,1-9H3,(H2,121,158)(H,128,135)(H,133,164)(H,134,177)(H,136,159)(H,137,160)(H,138,163)(H,139,170)(H,140,171)(H,141,175)(H,142,174)(H,143,169)(H,144,173)(H,145,165)(H,146,176)(H,147,178)(H,148,172)(H,149,166)(H,150,168)(H,151,167)(H,152,179)(H,161,162)(H,181,182)(H4,122,123,129)(H4,124,125,130)(H4,126,127,131)/t73-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87-,88-,89-,94-,95-,96-/s3
InChIKey: JMTCEFUSRHYJBF-LTFOILMJNA-N
SMILES: N1(CCC[C@H]1C(=O)N[C@@H](CC1C=CC=CC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1C=CC(=CC=1)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(O)=O)CC(N)=O)C(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1C=CC(=CC=1)O)NC(=O)[C@@H](NC(CNC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(O)=O)NC([C@H](CCSC)N)=O)=O)CC1C2C=CC=CC=2NC=1 |&1:4,8,19,25,36,43,50,60,68,80,91,99,114,120,131,143,150,157,165,r|

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

N-Bromosuccinimide Price

Tocris

Product number: 2568
Product name: MOG(35-55)
Packaging: 1
Price: $229
Updated: 2021/12/16

ApexBio Technology

Product number: A8306
Product name: MOG(35-55)
Packaging: 1mg
Price: $98
Updated: 2021/12/16

ApexBio Technology

Product number: A8306
Product name: MOG(35-55)
Packaging: 5mg
Price: $294
Updated: 2021/12/16

American Custom Chemicals Corporation

Product number: PEP0003907
Product name: MOG (35-55)-MOUSE, RAT
Purity: 95.00%
Packaging: 1MG
Price: $733.72
Updated: 2021/12/16

More

Less

Mog (35-55) Chemical Properties,Usage,Production

Description

MOG (35-55) or myelin oligodendrocyte glycoprotein (MOG) 35-55 is a minor component of CNS myelin. MOG (35-55) produces a relapsing-remitting neurological disease with extensive plaque-like demyelination, common to the manifestations of multiple sclerosis. MOG (35-55) induces strong T and B cell responses and is highly encephalitogenic. MOG (35-55) induces T cell-mediated multiple sclerosis in animal models. When co-administered with ITE, MOG (35-55) induces tolerogenic dendritic cells and suppresses disease development in mouse preclinical models of multiple sclerosis.

Uses

Mog (35-55) can be used as an antigen immunized C57BL/6J mice to induces severe chronic experimental autoimmune encephalomyelitis in transgenic mice.

Biological Activity

mog (35-55) is a truncated peptide derived from the human myelin oligodendrocyte glycoprotein (mog). mog, a member of the immunoglobulin superfamily, is expressed wildly in the central nervous system. in mouse and rat models for human multiple sclerosis, mog is involved in inducing the experimental autoimmune encephalomyelitis. humoral auto-immunity to the myelin oligodendrocyte glycoprotein (mog) may be associated with the pathogenesis of multiple sclerosis (ms) [1].mog (35-55) is involved in inducing autoantibody production and relapsing-remitting neurological disease causing extensive plaque-like demyelination [2]. in hla-dr2-transgenic mice, myelin oligodendrocyte glycoprotein-35-55 peptide induced severe chronic experimental autoimmune encephalomyelitis [3].mog35-55 was highly encephalitogenic and could induce strong t and b cell responses in rats [4]. in nod/lt mice (h-2g7) and c57bl/6 mice (h-2b), single injection of mog35-55 in cfa could induce ms-like disease [4].

in vivo

Myelin oligodendrocyte glycoprotein (MOG) peptide 35-55 is one of the targets of self-reactive T cell responses, leading to acute and later chronic autoimmune processes. MOG 35-55 is capable of inducing experimental autoimmune encephalomyelitis (EAE) in B6 mice^[1].

Induction of experimental autoimmune encephalomyelitis (EAE) model^[3]

Background

Myelin Oligodendrocyte Glycoprotein Peptide (35-55) CAN trigger an immune response against the CNS, and induces inflammation and destruction of myelin or antigen-bearing structures that causes neurological abnormalities.

Specific Modeling Methods

Mice: C57BL/6 background mice ? 2-4 months old ? male and female
Administration: On day 0: 3 mg/mL peptide plus CFA (4 mg/mL) ? Mix thoroughly 1: 1 peptide and CFA solutions ? s.c. ? 100 μL for each hind flank; ? On day 0 and day 2: 2.5 μg/mL of Bordetella pertussis toxin ? i.p. ? 200 μL

Note

1. Once peptide and CFA emulsion is formed, it can be stored at 4 °C for a few hours or used immediately.
2. Symptoms appear approximately 10-15 days after immunization.
3. When mice have clinical symptoms of EAE, hydrated food is placed on the cage floor to facilitate access to these mice.
4. Record parameters every other day at the beginning, and daily from 7th postimmunization day. Body weight decreases usually precedes EAE clinical signs and is a very objective and valuable measure.

Modeling Indicators

Evaluate changes in body weight and clinical scoring: body weight loss, loss of tail tonus, paralyzed tail, hind limb paraparesis, hind limb paralysis, front leg paralysis, tetraplegia, moribund, etc.
prototypical histopathological changes: Luxol fast blue staining of spinal cord for myelin evaluation shows infiltrates and demyelination in EAE animals.

Correlated Product(s): Complete Freund's adjuvant (CFA) (HY-153808)

Opposite Product(s): /

Animal Model:	HLA-DR2 (DRB1*1501) mice^[1]
Dosage:	200 μg (0.2 mL)
Administration:	Intraperitoneal injection; once, for 38 days
Result:	Resulted in paralysis of both hind and forelimbs.

storage

Store at -20°C

References

[1]. de march a k, de bouwerie m, kolopp-sarda m n, et al. anti-myelin oligodendrocyte glycoprotein b-cell responses in multiple sclerosis[j]. journal of neuroimmunology, 2003, 135(1): 117-125.
[2]. slavin a, ewing c, liu j, et al. induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein[j]. autoimmunity, 1998, 28(2): 109-120.
[3]. rich c, link j m, zamora a, et al. myelin oligodendrocyte glycoprotein‐35–55 peptide induces severe chronic experimental autoimmune encephalomyelitis in hla‐dr2‐transgenic mice[j]. european journal of immunology, 2004, 34(5): 1251-1261.
[4]. slavin a, ewing c, liu j, et al. induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein[j]. autoimmunity, 1998, 28(2): 109-120.

Mog (35-55) Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Mog (35-55) Suppliers

China 150 France 2 Germany 1 India 2 Japan 1 Switzerland 2 United Kingdom 3 United States 16 Global 177

Adachibio Inc.

Tel: +81-8027837258; +8108027837258
Fax: 0081-80278372055
Email: sales@adachibio.com
Country: Japan
ProdList: 992
Advantage: 58

More

Less

View Lastest Price from Mog (35-55) manufacturers

Shandong Hanjiang Chemical Co., Ltd

Product: Mog (35-55) 149635-73-4
Price: US $0.00-0.00/KG
Min. Order: 1KG
Purity: 99%
Supply Ability: 1T
Release date: 2025-10-07

RongNa Biotechnology Co.,Ltd

Product: Mog (35-55) 149635-73-4
Price: US $1.00/g
Min. Order: 1g
Purity: 99%
Supply Ability: 100kg
Release date: 2024-03-26

Shandong Hanjiang Chemical Co., Ltd

Product: MOG 35-55 149635-73-4
Price: US $0.00/kg
Min. Order: 1kg
Purity: 0.99
Supply Ability: 10T
Release date: 2024-01-11

149635-73-4, Mog (35-55)Related Search:

H-HIS-CYS-LEU-GLY-LYS-TRP-LEU-GLY-HIS-PRO-ASP-LYS-PHE-OH PLP (139-151) Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA) BIOT-MEVGWYRSPFSRVVHLYRNGK-OH Mog (35-55)

H-MET-GLU-VAL-GLY-TRP-TYR-ARG-SER-PRO-PHE-SER-ARG-VAL-VAL-HIS-LEU-TYR-ARG-ASN-GLY-LYS-OH

H-MET-GLU-VAL-GLY-TRP-TYR-ARG-SER-PRO-PHE-SER-ARG-VAL-VAL-HIS-LEU-TYR-ARG-ASN-GLY-LYS-OH (MOUSE, RAT)

MET-GLU-VAL-GLY-TRP-TYR-ARG-SER-PRO-PHE-SER-ARG-VAL-VAL-HIS-LEU-TYR-ARG-ASN-GLY-LYS

MEVGWYRSPFSRVVHLYRNGK

MK21

H-MEVGWYRSPFSRVVHLYRNGK-OH

MET-GLU-VAL-GLY-TRP-TYR-ARG-PRO-PRO-PHE-SER-ARG-VAL-VAL-HIS-LEU-TYR-ARG-ASN-GLY-LYS

MET-GLU-VAL-GLY-TRP-TYR-ARG-SER-PRO-PHE-SER-ARG-VAL-VAL-HIS-LEU-TYR-ARG-ASN-GLY-LYS: MEVGWYRSPFSRVVHLYRNGK

MOG (35-55) (rat, Mouse)

MYELIN OLIGODENDROCYTE GLYCOPRTOTEIN PEPTIDE FRAGMENT (33-55) RAT, MOUSE, MOG Peptide (33-55) Rat, Mouse

Myelin Oligodendrocyte Glycoprotien (35-55) rat MOG (35-55)

Myelin Oligodendrocyte Glycoprotein (35-55)

MOG(35-55)| Myelin Oligodendrocyte Glycoprotein Peptide: 35-55,rat,mouse

Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat

MYELIN OLIGODENDROCYTE GLYCOPROTEIN PEPTIDE (35-55) (RAT, MOUSE)

MYELIN OLIGODENDROCYTE GLYCOPROTEIN PEPTIDE FRAGMENT 35-55 RAT, MOUSE

MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55) (MOUSE, RAT)

MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55), RAT

MYELIN OLIGODENDROCYTE PROTEIN (35-55)

MOG (35-55), MOUSE, RAT

MOG (35-55), RAT

MOG (35-55)

MOG (MOUSE, RAT)

MOG PEPTIDE (35-55) (RAT, MOUSE)

MOG (RAT, MOUSE, 35-55)

L-Lysine, L-methionyl-L-α-glutamyl-L-valylglycyl-L-tryptophyl-L-tyrosyl-L-arginyl-L-seryl-L-prolyl-L-phenylalanyl-L-seryl-L-arginyl-L-valyl-L-valyl-L-histidyl-L-leucyl-L-tyrosyl-L-arginyl-L-asparaginylglycyl-

H-MET-GLU-VAL-GLY-TRP-TYR-ARG-SER-PRO-PHE-SER-ARG-VAL-VAL-HIS-LEU-TYR-ARG-ASN-GLY-LYS-OH USP/EP/BP

MOG (35-55) TFA

L-Lysine,L-methionyl-L-a-glutamyl-L-valylglycyl-L-tryptophyl-L-tyrosyl-L-arginyl-L-seryl-L-prolyl-L-phenylalanyl-L-seryl-L-arginyl-L-valyl-L-valyl-L-histidyl-L-leucyl-L-tyrosyl-L-arginyl-L-asparaginylglycyl-

(2S)-6-amino-2-[[2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-5-ca

Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55))

Myelin Oligodendrocyte Glycoprotein (35-55) (mouse, rat) trifluoroacetate

Myelin Oligodendrocyte Glycoprotein (35-55) (Mouse, rat)、MOG (35-55) (Mouse, rat)

149635-73-4

C118H177N35O29S

peptide

Various Peptides